There are molecules called GTP analogs that resemble GTP so closely that they can be bound by G proteins. However, they cannot be hydrolyzed by cellular GTPases. What differences in effect would you expect if you inject GTP or a nonhydrolyzable GTP analog into a liver cell that responds to glucagon?